Sort
10,766 grants matching “checkpoint inhibitor”
Molecular basis of neuronal dysfunction in AIDS
$249,728Francesca Peruzzi · Temple Univ Of The Commonwealth · R01 · FY2007 · MH
Advanced Genetic Engineering to Unravel Tumor-Specific B Cell Responses
$249,645Pietro Genovese · Boston Children'S Hospital · R21 · FY2025 · CA
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer
$249,645Chunyan Zhang · Beckman Research Institute/City Of Hope · R21 · FY2025 · CA
HDAC4 Viability: Unique Mechanisms and Function
$249,638University Of Pennsylvania · R01 · FY2005 · CA
HDAC4 Viability: Unique Mechanisms and Function
$249,638University Of Pennsylvania · R01 · FY2004 · CA
Structure and Function of SET Domain Methyltransferases
$249,605Raymond C Trievel · University Of Michigan At Ann Arbor · R01 · FY2010 · GM
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
$249,572Louis M Weiner · Georgetown University · P30 · FY2022 · CA
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy
$249,479Shana O Kelley · Northwestern University · R01 · FY2024 · CA
Designer EcN for treatment of solid tumors
$249,442Cammie Lesser · Massachusetts General Hospital · R21 · FY2022 · CA
Effects of DNA Damaging Agents on G2 Phase Checkpoint
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA
Effects of DNA Damaging Agents on G2 Phase Checkpoint
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
Checkpoint abrogation and MEK1/2 inhibition in myeloma
$249,375Virginia Commonwealth University · R01 · FY2005 · CA
Checkpoint abrogation and MEK1/2 inhibition in myeloma
$249,375Virginia Commonwealth University · R01 · FY2004 · CA
Effects of DNA Damaging Agents on G2 Phase Checkpoint
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
Effects of DNA Damaging Agents on G2 Phase Checkpoint
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Molecular Mode of Action of JAB-1 in Cell Proliferation
$249,375University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA
Project 1 - Dioxin-like Compounds Suppress IgM Responses by Targeting CD5+ (Innate-like) B cells, which can Serve as a Biomarker of Susceptibility to Environmental AHR Ligands
$249,272Norbert E Kaminski · Michigan State University · P42 · FY2024 · ES
Functional study of C53 protein as a novel regulator of checkpoint kinases
$249,232Honglin Li · Augusta University · R01 · FY2012 · GM
MECHANISMS OF DNA DAMAGE TRIGGERED S PHASE CHECKPOINTS
$249,131State University Of New York At Buffalo · R01 · FY2001 · CA
Small molecule inhibitors of oncogenic miR-21
$249,109Gabriele Varani · Ithax Pharmaceuticals, Inc. · R41 · FY2020 · CA
Administrative Core
$249,103Peter Karl Sorger · Harvard Medical School · U54 · FY2019 · CA
A PATHWAY OF TUMOR SUPPRESSION
$249,000University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA